Searched for
KYOWA
Lupin to divest entire stake in Kyowa for Rs 3,702 croreThe deal proceeds will be utilised to strengthen company's balance sheet.11 Nov, 2019, 08.42 PM IST- Lupin looks to sell Japanese arm Kyowa for $600 millionKyowa grew a modest 5% over the year-ago level. Its net profit halved to Rs 68.6 crore constituting 11.3% of Lupin’s consolidated profit. "...01 Nov, 2019, 08.54 AM IST
- Lupin divests Kyowa Criticare to Neopharma GroupShares of Lupin closed at Rs 737, up marginally by 0.02 per cent, on Thursday.23 Aug, 2019, 07.47 AM IST
- Tie-up with Fujifilm Kyowa to accelerate entry in European market: Kiran Mazumdar ShawIn Europe itself, biosimilars is almost a $4.5-bn opportunity and there are going to be only 3-4 players12 Apr, 2018, 04.23 PM IST
- Lupin arm in pact to distribute anti-depressant drug in JapanLupin President Dr. Fabrice Egros said the Astellas agreement reinforces Kyowa's transition toward a hybrid pharmaceutical specialty care c...27 Feb, 2017, 12.46 PM IST
- Lupin arm buys branded drugs from Japan’s ShionogiThe new branded product portfolio has a strong fit with Lupin’s Kyowa business, as it adds depth and reach to its current CNS (central nerv...03 Aug, 2016, 02.16 AM IST
- Lupin's subsidiary Kyowa to set up plant in JapanKyowa Pharmaceutical Industry Co is a wholly-owned subsidiary of the the Mumbai-based firm. It has a manufacturing facility at Sanda, Japan.29 Feb, 2016, 08.57 PM IST
- Lupin aims to double sales in Japan to $500 million in next 5 yearsDrug firm Lupin is targeting to double sales in Japan to $500 million (over Rs 2,600 crore) in the next five years on the back of enhanced ...30 Sep, 2012, 11.46 AM IST
- Lupin eyes USD 300 mn revenues from Japan in next 2 yearsDrug maker Lupin is eyeing a jump of over 80 per cent in its revenues to $300 million (about Rs 1,557 crore) from the Japanese market in th...11 Dec, 2011, 03.30 PM IST
- Lupin expects to launch 50 products globally in FY12Drug maker Lupin expects to launch nearly 50 products in the current fiscal in various markets across the globe, including up to 12 product...29 May, 2011, 01.35 PM IST
- Lupin aims to break into top 5 in Japanese marketDrug maker Lupin today said it is aiming to become one of the top five generic pharmaceutical companies in Japan in the next three years.17 Apr, 2011, 11.22 AM IST
- Daiichi to use Ranbaxy network to sell products in SingaporeRanbaxy and Daiichi Sankyo had signed a three-year plan to exploit synergies in operations to enhance their generic as well as branded busi...01 Mar, 2011, 06.08 PM IST
- Lupin scouts for buys in Latin AmericaThe company expects to launch 10 new products in Japan this year, considered the most difficult of three developed pharmaceutical markets -...06 Jan, 2011, 05.06 AM IST
- Lupin's Japanese arm gets nod to sell 10 productsThe company plans to launch these products by July 2008. Lupin is the first Indian co to get approval from the Japanese drug authorities to...25 Apr, 2008, 12.33 AM IST
- Lupin's Japanese arm gets nod for 10 productsLupin's Japanese subsidiary Kyowa Pharma has received approvals for 10 products and expects to launch these in July 2008 post NHI listing.23 Apr, 2008, 05.07 PM IST
- Lupin to shift Japanese arm’s manufacturing to IndiaIn a bid to improve the profitability of its Japanese venture Kyowa Pharmaceutical Industry, Indian drug maker Lupin is planning to bring t...03 Nov, 2007, 04.20 AM IST
- Lupin makes a leap into Japanese pharma marketLupin’s acquisition in Japan gives it a foothold in a large pharmaceutical market with relatively low generic penetration. Japan is the wor...11 Oct, 2007, 12.31 AM IST
Load More
